The Weekly Pulse: Edition 31 — April 26, 2026

Published · Researched 2026-09-22

Week of April 20, 2026 · Good Signal

The week in one paragraph

Kylo Jace spent seven years as the longest-staying dog at the SPCA of Anne Arundel County, Maryland — then on July 11, 2026, he went home. The shelter announced the adoption on its Facebook page the next day; People magazine picked the story up independently. Seven years of kennels, greetings, and being passed over ended in one confirmed forever home. For every long-stay animal still waiting, Kylo Jace is proof the math can change on any given day.

Rising

Playgrounds the community built. Two of them, on opposite coasts. In Richmond, Virginia, Chimborazo Elementary unveiled a kid-designed playground on June 25, 2026, built by volunteers with the CarMax Foundation and KABOOM! in under six hours — children designed the space, adults assembled it. In Grand Junction, Colorado, students themselves cut the ribbon on Chipeta Community Park, the payoff of a years-long parent-and-grandparent-led effort funded by a $550,000 Colorado Health Foundation grant plus city and school-district contributions, operating as a city park open to the whole neighborhood outside school hours. Still watching: volunteer counts and equipment details at Chimborazo, and the exact ribbon-cutting date at Chipeta, were not captured.
A whale supergroup. On December 30, 2025, photographers Chris and Monique Fallows documented 299 humpback whales feeding together off South Africa — independently verified individual by individual through Happywhale's photo-identification system, one of the largest supergroups ever recorded. The AP reported it in July 2026 as evidence that humpback numbers are rebounding from the whaling era. The caveat travels with it: the recovery reading is scientists' assessment, not a population census, and the same reporting flags shipping dangers as a risk framing — not a measured impact on this aggregation.
Alzheimer's, now bendable. The FDA approved donanemab (Kisunla) on July 2, 2024 — an amyloid-targeting infusion for early symptomatic Alzheimer's, and the first drug shown in a large trial to measurably slow the disease itself rather than just mask symptoms: about 22% slower clinical decline overall, up to 35% in less-advanced disease, roughly 37% lower risk of progression. It carries a boxed warning for ARIA — brain swelling and microbleeds — with brain MRI monitoring required, so this is a genuine advance with real limits. A physician's podcast account was fielding public questions about the treatment on Threads in September 2026, so the conversation is live beyond the press release. Still watching: pricing and real-world uptake were not verified.

Falling

Untreatable Alzheimer's. For the first time in the history of the disease, a drug slowed its course — not a cure, not for everyone, but medicine finally bending a decline it could previously only watch.
The whaling-era ocean. A 299-whale feeding aggregation, verified one animal at a time, is the opposite of the depleted decades that made such supergroups rare or absent.
The long-stay death spiral. Kylo Jace's seven-year wait ended in adoption — the "unadoptable" label breaking at its hardest test.

Quiet signals

Kisunla in the real world. Approval was 2024; the dossier could not verify cost or how many patients are actually receiving it, and the social layer is thin enough that the tier could not be finalized. Still watching.
Supergroup equals recovery? The ecological interpretation is scientists' read, not a census; regional humpback stock assessments were not cross-checked. Still watching.
Chipeta's ribbon date. Coverage confirms students cut it in 2026; the exact date was not extracted. Minor, but honest.

Scoreboard

N/A — editions are being written out of sequence, so there are no prior calls to grade.

One line to close: Seven years waiting, 299 whales feeding, one disease bending — patience, it turns out, is a strategy.